Latest filing published 13 Dec 2016 for Armata Pharmaceuticals, Inc., €1,381.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Steven Robert Martin: trading record in brief
Steven Robert Martin is a declared insider at 4 companies; the most frequent names are Armata Pharmaceuticals, Inc., Leap Wireless International Inc and Seelos Therapeutics, Inc. In total, 4 filings cover trades dated from 6 June 2007 to 9 December 2016.
On the market, this insider has only ever bought: 1 purchase, €44k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 2 share grants.
The newest entry dates from 13 December 2016: a share grant of €1,381, in Armata Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 4,917 days ago, on 24 May 2013. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Steven Robert Martin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,760 shares@ US$0.39100.0% of flowCommon StockSEC:0001209191-16-154878:0
- 20,000 shares@ US$2.85Common StockSEC:0001181431-13-030733:0Canonical exit: 21 Aug 2013 (T+90)
- 3,000 shares0Common StockSEC:0001237830-08-000021:0
- 6,317 shares@ US$10.94Common StockSEC:0001104659-07-046615:0
4 of 4 declarations
